title: Lack of detectable enhanced pulmonary histopathology in cotton rats immunized with purified F glycoprotein of respiratory syncytial virus (RSV) when challenged at 3-6 months after immunization.
abstract: The cotton rat model has been used to evaluate the potential for immunogens to induce respiratory syncytial virus (RSV)-enhanced pulmonary histopathology. A recent study evaluated purified F protein in this model when animals were challenged intranasally with RSV 3 or 6 months after immunization. The authors concluded that the purified F protein was associated with the same level of histopathological changes as observed with the positive control, a formalin-inactivated RSV immunogen. Three pathologists have independently evaluated the lung sections from the animals of this study and the results are reported in this article. In contrast to the previously published data, we have found that F protein was associated with a substantially milder and qualitatively different response to that observed with the formalin-inactivated RSV vaccine. We concluded that the minimal histological changes observed and lack of clinical disease make it very difficult to assess the issue of enhanced pulmonary RSV disease with the cotton rat model.
authors.affiliation: Virology Research, Praxis Biologics, Rochester, NY 14623.
authors.forename: S W
authors.initials: SW
authors.lastname: Hildreth
authors.forename: R R
authors.initials: RR
authors.lastname: Baggs
authors.forename: D G
authors.initials: DG
authors.lastname: Brownstein
authors.forename: W L
authors.initials: WL
authors.lastname: Castleman
authors.forename: P R
authors.initials: PR
authors.lastname: Paradiso
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D000956:Antigens, Viral / Q000276:immunology; D004195:Disease Models, Animal; D015707:HN Protein; D008168:Lung / Q000276:immunology / Q000473:pathology*; D012136:Respiratory Syncytial Viruses / Q000276:immunology*; D010253:Respirovirus Infections / Q000276:immunology / Q000473:pathology*; D016205:Sigmodontinae; D014611:Vaccination; D015164:Vaccines, Inactivated; D014759:Viral Envelope Proteins; D014764:Viral Proteins / Q000276:immunology*; D014765:Viral Vaccines / Q000633:toxicity*
chemical_list: D000956:Antigens, Viral; D015707:HN Protein; D015164:Vaccines, Inactivated; D014759:Viral Envelope Proteins; D014764:Viral Proteins; D014765:Viral Vaccines; C116204:attachment protein G